Wall‐Immobilized Biocatalyst vs. Packed Bed in Miniaturized Continuous Reactors: Performances and Scale‐Up
ChemBioChem · 03.06.2024 · 25 (11)
DOI: 10.1002/cbic.202400086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 10.05.2024. Verfasst von Maïté Michaud und 2 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, CEA, LITEN, DTCH, Laboratoire Composants et Systèmes Thermiques (LCST), F-38000, Grenoble, France. Hauptthemen laut MEDLINE: Enzymes, Immobilized, Bioreactors, Biocatalysis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CEA/LITEN - CARNOT project "MilliBiocat", Agence Nationale de la Recherche, Graduate School of Chemistry, Biology and Health of University Grenoble Alpes.
Abstract (Originalsprache)
Sustainable biocatalysis syntheses have gained considerable popularity over the years. However, further optimizations – notably to reduce costs – are required if the methods are to be successfully deployed in a range of areas. As part of this drive, various enzyme immobilization strategies have been studied, alongside process intensification from batch to continuous production. The flow bioreactor portfolio mainly ranges between packed bed reactors and wall‐immobilized enzyme miniaturized reactors. Because of their simplicity, packed bed reactors are the most frequently encountered at lab‐scale. However, at industrial scale, the growing pressure drop induced by the increase in equipment size hampers their implementation for some applications. Wall‐immobilized miniaturized reactors require less pumping power, but a new problem arises due to their reduced enzyme‐loading capacity. This review starts with a presentation of the current technology portfolio and a reminder of the metrics to be applied with flow bioreactors. Then, a benchmarking of the most recent relevant works is presented. The scale‐up perspectives of the various options are presented in detail, highlighting key features of industrial requirements. One of the main objectives of this review is to clarify the strategies on which future study should center to maximize the performance of wall‐immobilized enzyme reactors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Grenoble Alpes, CEA, LITEN, DTCH, Laboratoire Composants et Systèmes Thermiques (LCST), F-38000, Grenoble, France.
- Univ. Grenoble Alpes, CEA, LETI, DTIS, Plateforme de Recherche Intégration, fonctionnalisation de Surfaces et Microfabrication (PRISM), F-38000, Grenoble, France.
ORCID-Profile: Maïté Michaud, Guillaume Nonglaton, Zoé Anxionnaz-Minvielle
Förderung
- CEA/LITEN - CARNOT project "MilliBiocat"
- Agence Nationale de la Recherche
- Graduate School of Chemistry, Biology and Health of University Grenoble Alpes
Zitieren
APA
Michaud, M., Nonglaton, G., & Anxionnaz-Minvielle, Z. (2024). Wall‐Immobilized Biocatalyst vs. Packed Bed in Miniaturized Continuous Reactors: Performances and Scale‐Up. ChemBioChem, 25(11). https://doi.org/10.1002/cbic.202400086
Vancouver
Michaud M, Nonglaton G, Anxionnaz-Minvielle Z. Wall‐Immobilized Biocatalyst vs. Packed Bed in Miniaturized Continuous Reactors: Performances and Scale‐Up. ChemBioChem. 2024;25(11). doi:10.1002/cbic.202400086
BibTeX
@article{Michaud2024,
author = {Michaud, Maïté and Nonglaton, Guillaume and Anxionnaz-Minvielle, Zoé},
title = {Wall‐Immobilized Biocatalyst vs. Packed Bed in Miniaturized Continuous Reactors: Performances and Scale‐Up},
journal = {ChemBioChem},
year = {2024},
volume = {25},
number = {11},
doi = {10.1002/cbic.202400086}
}
EUVIMED